Full Schedule

07:00 – 08:00 CST

Breakfast Session: GC/CT Self-testing and Self-sampling roundtable with FDA

Location: Sheraton 3

Primary Presenter: – University of Alabama

07:00 – 08:00 CST

Breakfast Session: Writing a Scientific Manuscript

Location: Michigan A/B

Primary Presenter:

07:00 – 08:00 CST

Invite Only: IUSTI ExCo

Location: Mayfair

07:00 – 11:00 CST

Design-a-thon: Community Group

Location: Arkansas

07:00 – 11:00 CST

Design-a-thon: Early Career Research Group

Location: Mississippi

07:00 – 11:00 CST

Design-a-thon: Silver Group

Location: Ohio

07:00 – 11:00 CST

Design-a-thon: Traveller Group

Location: Colorado

08:30 – 09:30 CST

Plenary 5: Communicating Science through Comedy

Location: Sheraton 4/5

Moderator: – University of Alabama

Invited Talk

08:30 – 09:30 CST

PL5.1 - Communicating Science through Comedy

Location: Sheraton 4/5

Invited Speaker:

Invited Talk

10:00 – 11:30 CST

O13 - 2022 Mpox outbreak: Challenges and Innovations

Location: Michigan A/B

Moderator: – University of Washington

Moderator: – European Centre for Diseases Prevention and Control (ECDC)

10:00 – 10:15 CST

O13.1 - Mpox in Germany, 2022: a shift from event-linked travel-associated transmission to a large autochthonous outbreak

Location: Michigan A/B

Primary Presenter: – Robert Koch Institute

Epidemiology & Monitoring

10:15 – 10:30 CST

O13.2 - Clinically inapparent mpox cases among visitors of three anonymous HIV/STI testing centers in Berlin, Germany, April–October, 2022

Location: Michigan A/B

Primary Presenter: – Robert Koch Institute

Epidemiology & Monitoring

10:30 – 10:45 CST

O13.3 - Case-Control Study of Risk Factors Associated with Mpox, San Francisco, CA, July–October, 2022

Location: Michigan A/B

Primary Presenter: – San Francisco Department of Public Health

Epidemiology & Monitoring

10:45 – 11:00 CST

O13.4 - MPOX AMONG MSM IN THE NETHERLANDS PRIOR TO MAY 2022, A RETROSPECTIVE STUDY

Location: Michigan A/B

Primary Presenter: – Public Health Service Amsterdam and Amsterdam University Medical Centre

Epidemiology & Monitoring

11:00 – 11:15 CST

O13.5 - Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022

Location: Michigan A/B

Primary Presenter: – Public Health Service Amsterdam and Amsterdam University Medical Centre

Clinical Science

11:15 – 11:30 CST

O13.6 - Rectal and Pharyngeal Mpox PCR Testing of Men Who Have Sex with Men (MSM) Suggests that Rectal Testing is More Sensitive than Lesion Testing and that Most Infections Are Asymptomatic

Location: Michigan A/B

Primary Presenter: – University of Washington

Clinical Science

10:00 – 11:30 CST

Future of STI/HIV testing: Trends and Innovations

Location: Superior A/B

Moderator: – University of Washington

Moderator: – MDPH

10:00 – 10:15 CST

O14.1 - A Machine Learning Classifier to predict if Users will Return an Online Postal STI Test Kit using data captured during request processes

Location: Superior A/B

Primary Presenter: – Preventx

Epidemiology & Monitoring

10:15 – 10:30 CST

O14.2 - Engagement in STI/HIV self-sample testing among Native Americans in Oklahoma: analysis of a community-based social media campaign

Location: Superior A/B

Primary Presenter: – Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

Behavioral & Social Science

10:30 – 10:45 CST

O14.3 - Improving syphilis screening by early detection using Treponema pallidum Transcription Mediated Amplification assay

Location: Superior A/B

Primary Presenter: – Public Health Service of Amsterdam

Basic & Translational Science

10:45 – 11:00 CST

O14.4 - Evaluating the implementation of home-based sexual health care (Limburg4Zero) among men who have sex with men using the RE-AIM framework.

Location: Superior A/B

Primary Presenter: – Maastricht University

Implementation Science

11:00 – 11:15 CST

O14.5 - The impact of HIV/STI knowledge on HIV testing and sexual behaviors among American Indians in Southern California

Location: Superior A/B

Primary Presenter: – University of California, San Diego

Epidemiology & Monitoring

10:00 – 11:30 CST

Pathogenesis and prevention of Chlamydia trachomatis infections

Location: Sheraton 1

Moderator: – University of Alabama at Birmingham

Moderator: – University of Melbourne

10:00 – 10:15 CST

O15.1 - Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and fertility in women: final results of the Netherlands Chlamydia Cohort Study (NECCST)

Location: Sheraton 1

Primary Presenter: – National Institute For Public Health And The Environment (RIVM), Bilthoven, the Netherlands. Maastricht University, Maastricht, the Netherlands. zoie.alexiou@rivm.nl

Epidemiology & Monitoring

10:15 – 10:30 CST

O15.2 - Oral inoculation of Chlamydia trachomatis (CT) can lead to viable rectal CT infection

Location: Sheraton 1

Primary Presenter: – University of Washington

Epidemiology & Monitoring

10:30 – 10:45 CST

O15.3 - Do we understand rectal chlamydia infections in women? A study including different anatomical sites, quantification and viability of Chlamydia trachomatis in two Swedish STI-clinics

Location: Sheraton 1

Primary Presenter: – Department of Clinical Microbiology, Uppsala University Hospital, Uppsala, Sweden

Clinical Science

10:45 – 11:00 CST

O15.4 - Characterising CD4+ T cell responses to Chlamydia trachomatis in highly exposed young South African women

Location: Sheraton 1

Primary Presenter: – Institute of Infectious Disease and Molecular Medicine, University of Cape Town

Basic & Translational Science

11:00 – 11:15 CST

O15.5 - Evaluating Chlamydia trachomatis and Neisseria Gonorrhoeae screening among asymptomatic pregnant women to prevent preterm birth and low birth weight in Gaborone, Botswana.

Location: Sheraton 1

Primary Presenter: – University of California, San Diego

Epidemiology & Monitoring

11:15 – 11:30 CST

O15.6 - Chlamydia trachomatis IgG seropositivity: who becomes and remains positive?

Location: Sheraton 1

Primary Presenter: – National Institute For Public Health And The Environment (RIVM), Bilthoven, the Netherlands. Maastricht University, Maastricht, the Netherlands. zoie.alexiou@rivm.nl

Epidemiology & Monitoring

10:00 – 11:30 CST

Advances in accessing, analysing and disseminating STI data

Location: Sheraton 3

Moderator:

Invited Talk

10:05 – 10:25 CST

SY10.1 - Applying advances made during the COVID-19 pandemic to access and disseminate STI and sexual health data

Location: Sheraton 3

Invited Speaker: – UK Health Security Agency

Invited Talk

10:25 – 10:45 CST

SY10.2 - Chat STD? Enhancing Prevention, Surveillance, and Sexual Health with AI

Location: Sheraton 3

Invited Speaker: – CDC

Invited Talk

10:45 – 11:05 CST

SY10.3 - Filling in the gaps: Collecting and triangulating data to improve STI services

Location: Sheraton 3

Invited Speaker: – Johns Hopkins University School of Medicine

Invited Talk

11:05 – 11:25 CST

SY10.4 - STI data: What does the public actually want?

Location: Sheraton 3

Invited Speaker: – Centers for Disease Control and Prevention

Invited Talk

10:00 – 11:30 CST

New paradigms in Sexual Health

Location: Sheraton 4/5

Moderator: – Queen's University

Moderator: – Yale School of Public Health

Invited Talk

10:05 – 10:25 CST

SP5.1 - Will Vaccines for STIs Replace Antimicrobials?

Location: Sheraton 4/5

Invited Speaker: – Western Sydney Sexual Health Centre (WSLHD)

Invited Talk

10:25 – 10:45 CST

SP5.2 - STI and Youth: Addressing Root Causes

Location: Sheraton 4/5

Invited Speaker: – Advocates for Youth

Invited Talk

10:45 – 11:05 CST

SP5.3 - Key population-led health services

Location: Sheraton 4/5

Invited Speaker: – Northwestern University-Institute for Sexual and Gender Minority Health and Wellbeing

Invited Talk

11:05 – 11:25 CST

SP5.4 - Indigenous perspectives in sexual health

Location: Sheraton 4/5

Invited Speaker: – CAAN Communities, Alliances & Neworks

Invited Talk

10:00 – 11:30 CST

Controlling syphilis - innovative approaches

Location: Sheraton 2

Moderator: – Melbourne Sexual Health Centre, Alfred Health and Central Clinical School, Monash University

Moderator:

Invited Talk

10:05 – 10:25 CST

SY9.1 - Doxycycline Post-exposure prophylaxis (PEP) & PrEP for Syphilis Prevention

Location: Sheraton 2

Invited Speaker: – Zuckerberg San Francisco General Hospital, UCSF, San Francisco, CA

Invited Talk

10:25 – 10:45 CST

SY9.2 - Whole genome sequencing for Treponema pallidum: how it can be applied to the real world to better understand syphilis outbreaks

Location: Sheraton 2

Invited Speaker: – London School of Hygiene and Tropical Medicine

Invited Talk

10:45 – 11:05 CST

SY9.3 - Recent studies and current understanding of the infectiousness of syphilis and novel PCR testing for Treponema pallidum including saliva

Location: Sheraton 2

Invited Speaker: – Shanghai Skin Disease Hospital

Invited Talk

11:05 – 11:25 CST

SY9.4 - Strategies to prevent congenital syphilis

Location: Sheraton 2

Invited Speaker: – Centers for Disease Control/DSTDP

Invited Talk

11:30 – 13:00 CST

Atlas of Queer Anatomy Workshop - Sign up Requested

Location: Erie

Invited Speaker: – Public Health Service Amsterdam and Amsterdam University Medical Centre

11:30 – 13:00 CST

Lunch Session: Setting up a remote/home testing STI programme: a practical toolkit (Lunch is only available to session attendees)

Location: Sheraton 4/5

11:30 – 13:00 CST

Lunch Session: Hot Talks in Sexually Transmitted Disease Prevention (Lunch is only available to session attendees)

Location: Sheraton 2

13:00 – 15:00 CST

Closing session

Location: Sheraton 4/5

Moderator: – University of Alabama

15:00 – 18:00 CST

Invite Only: ASTDA BOD

Location: Mayfair